Vecuronium Disease Interactions
There are 3 disease interactions with vecuronium.
Neuromuscular blocking agents (applies to vecuronium) liver disease
Major Potential Hazard, High plausibility.
Neuromuscular blocking agents undergo metabolism by the liver. Elimination and effects may be prolonged in patients with liver disease. Therapy with neuromuscular blocking agents should be administered cautiously in patients with liver disease.
References
- (2001) "Product Information. Zemuron (rocuronium)." Organon
- (2001) "Product Information. Mivacron (mivacurium)." Glaxo Wellcome
- (2001) "Product Information. Nuromax (doxacurium)." Glaxo Wellcome
- (2001) "Product Information. Norcuron (vecuronium)." Organon
- (2001) "Product Information. Metubine Iodide (metocurine)." Dista Products Company
Neuromuscular blocking agents (applies to vecuronium) paresis
Major Potential Hazard, High plausibility. Applicable conditions: Paralytic Disorder
Patients with hemiparesis or paraparesis may require higher dosages of non-depolarizing neuromuscular blocking agents in the affected limbs. Neuromuscular monitoring should be performed on a non-paretic limb to avoid inaccurate dosing.
References
- (2001) "Product Information. Zemuron (rocuronium)." Organon
- (2001) "Product Information. Mivacron (mivacurium)." Glaxo Wellcome
- (2001) "Product Information. Nuromax (doxacurium)." Glaxo Wellcome
- (2001) "Product Information. Tracrium (atracurium)." Glaxo Wellcome
- (2001) "Product Information. Norcuron (vecuronium)." Organon
- (2001) "Product Information. Metubine Iodide (metocurine)." Dista Products Company
Neuromuscular blocking agents (applies to vecuronium) pulmonary impair
Major Potential Hazard, High plausibility. Applicable conditions: Pulmonary Impairment
Neuromuscular blocking agents can cause respiratory depression and paralysis. Therapy with neuromuscular blocking agents should be administered cautiously in patients with pulmonary impairment. Treatment of respiratory paralysis consists of positive-pressure artificial respiration with oxygen and maintenance of a patent airway until the recovery of normal respiration is assured.
References
- (2001) "Product Information. Zemuron (rocuronium)." Organon
- (2001) "Product Information. Anectine (succinylcholine)." Glaxo Wellcome
- (2001) "Product Information. Mivacron (mivacurium)." Glaxo Wellcome
- (2001) "Product Information. Nuromax (doxacurium)." Glaxo Wellcome
- (2001) "Product Information. Tracrium (atracurium)." Glaxo Wellcome
- (2001) "Product Information. Norcuron (vecuronium)." Organon
- (2001) "Product Information. Metubine Iodide (metocurine)." Dista Products Company
Vecuronium drug interactions
There are 184 drug interactions with vecuronium.
More about vecuronium
- vecuronium consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Latest FDA alerts (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: neuromuscular blocking agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.